Health CarePharmaceuticals & Biotechnology
  • Price (EUR)49.09
  • Today's Change1.00 / 2.08%
  • Shares traded109.16k
  • 1 Year change59.18%
  • Beta1.0501
Data delayed at least 15 minutes, as of Aug 30 2016 09:51 BST.
More ▼

Key statistics

As of last trade Stada Arzneimittel AG (SAZX.N:GER) traded at 49.09, -3.86% below its 52-week high of 51.06, set on Aug 18, 2016.
52-week range
Today
28.05Feb 09 201651.06Aug 18 2016
Markit short selling activity
Low
Med
High
Open49.10
High49.72
Low48.77
Bid49.06
Offer49.11
Previous close48.09
Average volume231.19k
Shares outstanding62.34m
Free float59.19m
P/E (TTM)34.47
Market cap3.00bn EUR
EPS (TTM)1.40 EUR
Annual div (IAD)0.5154 EUR
Annual div yield (IAD)1.07%
Div ex-dateAug 29 2016
Div pay-dateAug 29 2016
Data delayed at least 15 minutes, as of Aug 30 2016 09:51 BST.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.